Patellofemoral osteoarthritis affects the knee joint where the kneecap meets the thigh bone, causing pain and limited mobility. Arthrosamid, a novel polyacrylamide hydrogel injection, offers a promising non-surgical treatment by cushioning the joint and reducing friction. Clinical studies highlight its safety and lasting pain relief, often improving function after a single outpatient procedure. Personalized expert care, such as that provided by orthopaedic specialists, is crucial for effective management. Arthrosamid provides an innovative option for patients with knee osteoarthritis, especially those with patellofemoral involvement, complementing physiotherapy and other treatments. Consult a qualified healthcare professional to determine if Arthrosamid suits your needs and to optimize your knee health strategy.
Arthrosamid® offers a minimally invasive treatment for knee osteoarthritis by injecting a cross-linked polyacrylamide hydrogel to cushion the joint, reduce pain, and improve mobility. Clinical studies demonstrate significant, lasting pain relief and enhanced function for up to two years, with a strong safety profile and minimal side effects. This innovative therapy integrates seamlessly into holistic osteoarthritis care including rehabilitation, weight management, and physiotherapy. Led by experts like Professor Paul Lee at MSK Doctors, patients receive tailored, compassionate care aimed at improving quality of life. Arthrosamid® is a promising option for those seeking effective, non-surgical relief from knee OA symptoms.
Arthrosamid is a novel injectable hydrogel treatment offering durable pain relief for patellofemoral osteoarthritis, especially effective in patients under 70 with moderate joint changes. This minimally invasive procedure improves joint lubrication and reduces mechanical stress, protecting cartilage from wear. Clinical studies demonstrate Arthrosamid’s advantages over traditional treatments, enhancing knee function and symptom management. Administered under expert care at MSK Doctors, it represents a promising option for knee osteoarthritis management. Ongoing research aims to optimize patient selection and long-term outcomes.
